Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Meiling Chu
Observed name:
Mei-Ling Chu
Institutions:
Shanghai University of Traditional Chinese Medicine,
Longhua Hospital Shanghai University of Traditional Chinese Medicine,
Seventh People's Hospital of Shanghai
Observed institutions:
Shanghai University of Traditional Chinese Medicine,
Longhua Hospital Shanghai University of Traditional Chinese Medicine,
Seventh People's Hospital of Shanghai
ORCID:
0000-0002-5600-4217
Observed ORCID:
0000-0002-5600-4217
OpenAlex ID:
A5030621457
SOCS3: An Immunological Biomarker Offering Potential Therapeutic Targets for Malignant Tumors
2025
·
Yan Zhang
, Meiling Chu
, et al.
·
Biological Procedures Online
·
14
PDF
Association between endocrine therapy and cognitive decline in breast cancer based on propensity score matching
2023
·
Yulian Yin
, Lan Jin
, et al.
·
Frontiers in Medicine
·
10
PDF
Breast Cancer Bone Metastasis: Novel Prognostic Biomarkers Identified
2025
·
Meiling Chu
, Yan Zhang
, et al.
·
Phenomics
·
5
Effects of the efficacy of the Yi Shen Tiao Gan formula on aromatase inhibitor associated musculoskeletal syndrome: a randomized controlled trial
2025
·
Yan Zhang
, Meiling Chu
, et al.
·
Frontiers in Pharmacology
·
3
PDF
Yi Shen Tiao Gan decoction alleviates aromatase inhibitor–related bone loss by promoting H-type vessel formation
2025
·
Meiling Chu
, Yan Zhang
, et al.
·
Translational Oncology
·
3
Construction and validation of a risk prediction model for aromatase inhibitor-associated bone loss
2023
·
Meiling Chu
, Yue Zhou
, et al.
·
Frontiers in Oncology
·
3
PD-1 blockade elicits a systemic immune response but not in the tumor of TNBC mice
2025
·
Xiaodan Hong
, Mei Ma
, et al.
·
Acta Biochimica et Biophysica Sinica
·
1
A study on the development of a machine learning-based clinical prediction model for bone health management in breast cancer patients
2025
·
Meiling Chu
, Xiaowen Lai
, et al.
·
Research Square
·
1
PDF
RGS9BP and SOCS3: novel biomarkers for prognostic evaluation of bone metastasis in breast cancer
2025
·
Yan Zhang
, Hui Cong
, et al.
·
Medical Data Mining
·
1
Molecular mechanism of Ruxian Shuhou prescription in the treatment of triple-negative breast cancer based on network pharmacology
2023
·
Meiling Chu
, Tian Meng
, et al.
·
Medicine
·
1
Experimental study on the establishment of Aromatase inhibitor associated bone loss model after premenopausal breast cancer and the mechanism of bone loss
2023
·
Meiling Chu
, Yulian Yin
, et al.
·
Journal of Clinical Densitometry
Survival Analysis of Skeletal Related Events in HR+ Breast Cancer Patients Based on Single NucleotidePolymorphism of ERα Gene
2023
·
Yulian Yin
, Yiwei Fan
, et al.
·
Journal of Clinical Densitometry
Show more works
View as search
Works count:
12
Citation count:
42
H-index:
3
I10-index:
2
Year
Topic
Type